IniXium and Peak Proteins – Stronger Together

As you will recall, Peak Proteins were acquired by Sygnature Discovery in April 2022. Now, that Sygnature have subsequently completed the acquisition of NuChem Sciences and their subsidiaries IniXium and OmegaChem in July this year, we are delighted to combine IniXium (based in Montreal, Canada) and Peak Proteins (based in Cheshire, UK) in to one Protein Science and Structural Biology division. Together, Sygnature Discovery now provides one of the largest groups of protein scientists dedicated to drug discovery in the CRO world.

Sygnature Discovery’s combined Protein Science and Structural Biology division offers an incredible breadth and depth of expertise in the field of protein expression, purification and structural biology, with a strong track record in delivering support to many diverse projects. To date, both organisations have provided high quality proteins and supported several structure-based drug discovery programs for clients throughout the globe. Now with two sites on either side of the Atlantic, that support will provide customers with an unrivalled offering in the market. An overview of our combined services is shown below.

The “Barn” – IniXium’s labs and offices near Montreal, Canada.

Birchwood House – Peak Proteins’ labs and offices Cheshire, UK.

Richard Mott: Scientific Bus. Dev. Director at Peak Proteins comments….“As soon as Sygnature Discovery brought us together, it was obvious that we have a huge amount in common. Most obvious and most pleasing, is our shared love of protein science and an unquenchable thirst for excellence. We always work collaboratively with our customers to understand the intricate detail of the science behind their projects, so that we can bring the full depth of our experience to bear when tackling any new request for Protein Science and Structural support. In addition, our complementary expertise, capabilities and cutting-edge equipment make transferring protocols between us very easy. In fact, we have already started collaborating on projects”.

Both sites provide any of these services as a standalone offering, or as part of a wider integrated drug discovery project where they work closely together with the other departments within Sygnature as required. These are provided with various contract model options that are aimed to meet  clients’ needs.

Should any of these services be of interest to you, please don’t hesitate to get in touch via info@peakproteins.com or info@inixium.com, or info@sygnaturediscovery.com